AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 Years experience of French Guiana

AIDS

Volumn 22, Issue 9, 2008, Pages 1047-1053

  Huber, Florence ^a,c   Nacher, Matthieu ^a   Aznar, Christine ^a   Pierre Demar, Magalie ^a   El Guedj, Myriam ^a   Vaz, Tania ^a   Vantilcke, Vincent ^a   Mahamat, Abba ^a   Magnien, Christian ^a   Chauvet, Elodie ^b   Carme, Bernard ^a   Couppié, Pierre ^a  

^a Andree Rosemon Hospital   (French Guiana)

^b Internal Medicine Unit   (French Guiana)

^c CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

Author keywords

Diagnosis; French Guiana; Histoplasmosis; HIV; Presumptive treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B; ASPARTATE AMINOTRANSFERASE; DEOXYCHOLIC ACID; FLUCONAZOLE; ITRACONAZOLE; LACTATE DEHYDROGENASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN DETECTION; ARTICLE; BONE MARROW BIOPSY; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEVER; FRENCH GUIANA; GASTROINTESTINAL DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN TISSUE; LIVER CELL CULTURE; LUNG DISEASE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TIME SERIES ANALYSIS; TISSUE CULTURE; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOLOGICAL MARKERS; FEMALE; FRENCH GUIANA; HISTOPLASMA; HISTOPLASMOSIS; HIV INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 44449094957     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282ffde67     Document Type: Article

References (22)

1. World Health Organisation (WHO). WHO case definition of HIV for surveillance and revised clinical staging and immunological classification; 2006. http://www.cdc.gov/MMWR/preview/MMWRhtml/00018871.htm. [Accessed 23 October 2007].
2. Centers for Disease Control and Prevention (CDC). Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults; 1993. http://www.who.int/ hiv/pub/guidelines/hivstaging/en/. [Accessed 23 October 2007]
3. Couppié P, Sobesky M, Aznar C, Bichat S, Clity E, Bissuel F, et al. Histoplasmosis and acquired immunodeficiency syndrome: a study of pronostic factors. Clin Infect Dis 2004; 38:134-138.
4. Lewden C, Sobeski M, Cabie A, Couppié P, Boulard F, Bissuel F, et al. Causes of death among HIV-infected adults in French Guiana and the West Indies in the area of highly active antiretroviral therapy (HAART). Med Mal Infect 2004; 34:286-292.
5. Nacher M, Aznar C, Blanchet D, Demar M, El Quedj M, Vaz T, et al. AIDS-related disseminated histoplasmosis in the greater Caribbean: how frequent is it? AIDS 2006; 20:951-952.
6. Couppié P, Aznar C, Carme B, Nacher M. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment and prognosis. Curr Opin Infect Dis 2006; 19:443-449.
7. Spinello A, Magni C, Nebuloni M, Parravicini C, Corbellino M, Sollima S, et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe. Report of 4 cases and review of the literature. Medicine 2006; 85:22-36.
8. INSEE. Atlas of immigrant population in French Guiana; 2006. http://www.insee.fr/fr/insee_regions/guyane/publi/Atlas_immigres_gy.pdf. [Accessed 23 October 2007]
9. Nacher M, Sarazin F, El Quedj M, Vaz T, Alvarez F, Nasser V, et al. Increased incidence of disseminated histoplasmosis following highly antiretroviral therapy initiation. J Acquir Immune Defic Syndr 2006; 41:468-470.
10. Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis 2005; 40:1199-1202.
11. Severo LC, Oliveira F, Irion K, Porto N, Londero AT. Histoplasmosis in Rio Grande do Sul, Brasil: a 21 year experience. Rev Inst Med Trop Sao Paulo 2001; 43:183-187.
12. Karimi K, Wheat J, Connoly P, Cloud G, Hajjeh R, Wheat E, et al. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 2002; 186:1655-1660.
13. Couppié P, Clity E, Nacher M, Aznar C, Sainte-Marie D, Carme B, et al. AIDS-related oral and/or cutaneous histoplasmosis: a descriptive and comparative study of 21 cases in French Guiana. Int J Dermatol 2002; 42:571-576.
14. Corcoran GR, Al-Abdely H, Flanders CD, Geimer J, Patterson TF. Markely elevated serum lactate deshydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1997; 24:942-944.
15. Wheat JL, Chetchotisakd P. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 2000; 30:877-881.
16. Daher EF, Silva GB Jr, Barros FA, Takeda CF, Mota RM, Ferreira MT, et al. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop Med Int Health 2007; 12:1108-1115.
17. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Lyod JE, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45:807-825.
18. Couppié P, Aznar C, Carme B, Nacher M. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis 2006; 19:443-449.
19. Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002; 137:105-109.
20. Wheat LJ, Connoly-Stringfield PA, Baker RL, Curfman MF, Eads ME, Israel KS, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361-374.
21. Hajjeh RA, Pappas PG, Henderson H, Lancaster D, Bamberger DM, Skahan KJ, et al. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus infected persons. Clin Infect Dis 2001; 32:1215-1220.
22. Leimann BC, Pizzini CV, Muniz MM, Albuquerque PC, Monteiro PCF, Reis RS, et al. Histoplasmosis in a Brazilian center: clinical forms and laboratory tests. Rev Iberoam Micol 2005; 22:141-146.